S Schneeweiss

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi request reprint What is Germany's experience on reference based drug pricing and the etiology of adverse health outcomes or substitution?
    S Schneeweiss
    Harvard School of Public Health, Boston, MA 02115, USA
    Health Policy 44:253-60. 1998
  2. ncbi request reprint Use of comorbidity scores for control of confounding in studies using administrative databases
    S Schneeweiss
    Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
    Int J Epidemiol 29:891-8. 2000
  3. ncbi request reprint On the evaluation of drug benefits policy changes with longitudinal claims data: the policy maker's versus the clinician's perspective
    S Schneeweiss
    Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
    Health Policy 55:97-109. 2001
  4. doi request reprint Active safety monitoring of newly marketed medications in a distributed data network: application of a semi-automated monitoring system
    J J Gagne
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Clin Pharmacol Ther 92:80-6. 2012
  5. pmc Refilling and switching of antiepileptic drugs and seizure-related events
    J J Gagne
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Clin Pharmacol Ther 88:347-53. 2010
  6. doi request reprint Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges
    D H Solomon
    Division of Pharmacoepidemiology, Brigham and Women s Hospital, 75 Francis Street, Boston, MA, USA
    Osteoporos Int 24:237-44. 2013
  7. doi request reprint Assessing the comparative effectiveness of newly marketed medications: methodological challenges and implications for drug development
    S Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Clin Pharmacol Ther 90:777-90. 2011
  8. doi request reprint Drugs that inhibit gastric acid secretion may alter the course of inflammatory bowel disease
    P Juillerat
    MGH Crohn s and Colitis Center, Department of Gastroenterology and Hepatology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
    Aliment Pharmacol Ther 36:239-47. 2012
  9. ncbi request reprint Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data
    S Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Am J Epidemiol 154:854-64. 2001
  10. ncbi request reprint [Patient-centered evaluation of the health status in a longitudinal quality management system in the hospital]
    S Schneeweiss
    Harvard Medical School, Boston, USA
    Gesundheitswesen 63:205-11. 2001

Detail Information

Publications11

  1. ncbi request reprint What is Germany's experience on reference based drug pricing and the etiology of adverse health outcomes or substitution?
    S Schneeweiss
    Harvard School of Public Health, Boston, MA 02115, USA
    Health Policy 44:253-60. 1998
    ..The introduction of RBP in British Columbia in 1995-1997 and its computerized administrative health databases covering a large proportion of the population should give rise to a thorough analysis of this policy...
  2. ncbi request reprint Use of comorbidity scores for control of confounding in studies using administrative databases
    S Schneeweiss
    Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
    Int J Epidemiol 29:891-8. 2000
    ..Our objective was to compare metrical and practical properties of published comorbidity scores for use in epidemiological research with administrative databases...
  3. ncbi request reprint On the evaluation of drug benefits policy changes with longitudinal claims data: the policy maker's versus the clinician's perspective
    S Schneeweiss
    Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
    Health Policy 55:97-109. 2001
    ....
  4. doi request reprint Active safety monitoring of newly marketed medications in a distributed data network: application of a semi-automated monitoring system
    J J Gagne
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Clin Pharmacol Ther 92:80-6. 2012
    ..3 cases per 1,000 person-years (95% CI: -0.5, 1.0). In a setting in which false positivity is a major concern, the system did not generate alerts for the three drug-outcome pairs...
  5. pmc Refilling and switching of antiepileptic drugs and seizure-related events
    J J Gagne
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Clin Pharmacol Ther 88:347-53. 2010
    ..19 (95% CI 0.35-3.99). Refilling the same AED prescription was associated with an elevated risk of seizure-related events whether or not the refill involved switching from a brand-name to a generic product...
  6. doi request reprint Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges
    D H Solomon
    Division of Pharmacoepidemiology, Brigham and Women s Hospital, 75 Francis Street, Boston, MA, USA
    Osteoporos Int 24:237-44. 2013
    ..We examined the literature and two new cohorts for BONJ. The literature suggests an incidence rate of 0.028 % to 4.3 %. Our cohort studies found an incidence of 0.02 % (95 % CI 0.004 %-0.11 %)...
  7. doi request reprint Assessing the comparative effectiveness of newly marketed medications: methodological challenges and implications for drug development
    S Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Clin Pharmacol Ther 90:777-90. 2011
    ....
  8. doi request reprint Drugs that inhibit gastric acid secretion may alter the course of inflammatory bowel disease
    P Juillerat
    MGH Crohn s and Colitis Center, Department of Gastroenterology and Hepatology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
    Aliment Pharmacol Ther 36:239-47. 2012
    ....
  9. ncbi request reprint Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data
    S Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Am J Epidemiol 154:854-64. 2001
    ..7% and 6.2%, respectively) for predicting mortality. Generalizability of results may be limited to an elderly, predominantly White population with equal access to state-funded health care...
  10. ncbi request reprint [Patient-centered evaluation of the health status in a longitudinal quality management system in the hospital]
    S Schneeweiss
    Harvard Medical School, Boston, USA
    Gesundheitswesen 63:205-11. 2001
    ..The objective was to assess the value of self-reported health status as an indicator of outcomes of acute hospital care, to identify potential practical limitations, and develop strategies for future applications...
  11. pmc Developments in post-marketing comparative effectiveness research
    S Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Clin Pharmacol Ther 82:143-56. 2007
    ....